Zentalis grants stock options for 136,000 shares to four new employees
ZNTL•Zentalis Pharmaceuticals granted options covering 136,000 shares to four new employees on November 2, 2026. The options have a 10-year term and vest over four years, subject to continued service.
1. Option grant terms
The options were granted under the 2022 Employment Inducement Incentive Award Plan. Twenty-five percent vest on the first anniversary of the vesting commencement date, with the remaining 75% vesting monthly over the next three years; each installment requires continued service.
